Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Epirubicin plus Cyclophosphamide|DRUG: Taxanes|DRUG: Taxanes plus Carboplatin
Sponsor: Shanghai Jiao Tong University School of Medicine